Ted Fjällman

Ted Fjällman is Partner at Flerie Invest, a European biotech and pharma investor managing a portfolio of more than 20 companies in the US, UK, Sweden and other countries. Ted has been CEO and board member of several biotech companies engaged in a wide range of areas including immunology, oncology and biologics development and manufacturing. He holds a Ph.D. in Biotechnology and Immunology from the University of Guelph, Canada and splits his time between the UK, Sweden and Switzerland